» Articles » PMID: 23840917

NADPH Oxidase As a Therapeutic Target for Oxalate Induced Injury in Kidneys

Overview
Publisher Wiley
Date 2013 Jul 11
PMID 23840917
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

A major role of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase family of enzymes is to catalyze the production of superoxides and other reactive oxygen species (ROS). These ROS, in turn, play a key role as messengers in cell signal transduction and cell cycling, but when they are produced in excess they can lead to oxidative stress (OS). Oxidative stress in the kidneys is now considered a major cause of renal injury and inflammation, giving rise to a variety of pathological disorders. In this review, we discuss the putative role of oxalate in producing oxidative stress via the production of reactive oxygen species by isoforms of NADPH oxidases expressed in different cellular locations of the kidneys. Most renal cells produce ROS, and recent data indicate a direct correlation between upregulated gene expressions of NADPH oxidase, ROS, and inflammation. Renal tissue expression of multiple NADPH oxidase isoforms most likely will impact the future use of different antioxidants and NADPH oxidase inhibitors to minimize OS and renal tissue injury in hyperoxaluria-induced kidney stone disease.

Citing Articles

Plasma metabolites as mediators in immune cell-pancreatic cancer risk: insights from Mendelian randomization.

Zhang K, Zhu J, Wang P, Chen Y, Wang Z, Ge X Front Immunol. 2024; 15:1402113.

PMID: 38933268 PMC: 11199692. DOI: 10.3389/fimmu.2024.1402113.


Cyclosporine-induced kidney damage was halted by sitagliptin and hesperidin via increasing Nrf2 and suppressing TNF-α, NF-κB, and Bax.

Abd-Eldayem A, Makram S, Messiha B, Abd-Elhafeez H, Abdel-Reheim M Sci Rep. 2024; 14(1):7434.

PMID: 38548778 PMC: 10978894. DOI: 10.1038/s41598-024-57300-x.


Models of gouty nephropathy: exploring disease mechanisms and identifying potential therapeutic targets.

Wang L, Zhang X, Shen J, Wei Y, Zhao T, Xiao N Front Med (Lausanne). 2024; 11:1305431.

PMID: 38487029 PMC: 10937455. DOI: 10.3389/fmed.2024.1305431.


Nifuroxazide attenuates indomethacin-induced renal injury by upregulating Nrf2/HO-1 and cytoglobin and suppressing NADPH-oxidase, NF-κB, and JAK-1/STAT3 signals.

Hassanein E, Abdel-Reheim M, Althagafy H, Hemeda M, Gad R, Abdel-Sattar A Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(6):3985-3994.

PMID: 37994949 DOI: 10.1007/s00210-023-02851-5.


The Protective Role of Dietary Polyphenols in Urolithiasis: Insights into Antioxidant Effects and Mechanisms of Action.

Hong S, Qin B Nutrients. 2023; 15(17).

PMID: 37686790 PMC: 10490426. DOI: 10.3390/nu15173753.


References
1.
Belostotsky R, Seboun E, Idelson G, Milliner D, Becker-Cohen R, Rinat C . Mutations in DHDPSL are responsible for primary hyperoxaluria type III. Am J Hum Genet. 2010; 87(3):392-9. PMC: 2933339. DOI: 10.1016/j.ajhg.2010.07.023. View

2.
Keaney Jr J, Xu A, Cunningham D, Jackson T, Frei B, Vita J . Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. J Clin Invest. 1995; 95(6):2520-9. PMC: 295934. DOI: 10.1172/JCI117953. View

3.
Sun Y, Asnicar M, Smith R . Central and peripheral roles of ghrelin on glucose homeostasis. Neuroendocrinology. 2007; 86(3):215-28. DOI: 10.1159/000109094. View

4.
Cayatte A, Rupin A, Maitland K, Sansilvestri-Morel P, Boussard M, Wierzbicki M . S17834, a new inhibitor of cell adhesion and atherosclerosis that targets nadph oxidase. Arterioscler Thromb Vasc Biol. 2001; 21(10):1577-84. DOI: 10.1161/hq1001.096723. View

5.
t Hart B, Simons J, Bakker N, Labadie R . Antiarthritic activity of the newly developed neutrophil oxidative burst antagonist apocynin. Free Radic Biol Med. 1990; 9(2):127-31. DOI: 10.1016/0891-5849(90)90115-y. View